Nuevos farmacos en insuficiencia cardíaca

Translated title of the contribution: New pharmacological agents in heart failure

Gustavo Lopera, Agustin Castellanos, Eduardo De Marchena

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Heart failure is a common and growing public health problem, with increasing incidence and prevalence over the last 2 decades. Despite improvements in its current management, heart failure is still associated with significant morbidity and mortality. This has motivated the search for newer therapeutic modalities, which are based on a better understanding on the pathophysiologic events that lead to heart failure. This review summarizes the potential role of new pharmacological agents in the treatment of heart failure. These potential new agents can be classified according to their role in the modulation of the main pathophysiologic abnormalities that characterized heart failure, that include: cellular-extracellular abnormalities, endothelial dysfunction, neurohormonal and immunologic activation.

Original languageSpanish
Pages (from-to)624-634
Number of pages11
JournalRevista Espanola de Cardiologia
Volume54
Issue number5
StatePublished - May 1 2001
Externally publishedYes

Fingerprint

Heart Failure
Pharmacology
Treatment Failure
Public Health
Morbidity
Mortality
Incidence
Therapeutics

Keywords

  • Heart failure
  • New pharmacological agents
  • Pathophysiology

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Nuevos farmacos en insuficiencia cardíaca. / Lopera, Gustavo; Castellanos, Agustin; De Marchena, Eduardo.

In: Revista Espanola de Cardiologia, Vol. 54, No. 5, 01.05.2001, p. 624-634.

Research output: Contribution to journalArticle

Lopera, G, Castellanos, A & De Marchena, E 2001, 'Nuevos farmacos en insuficiencia cardíaca', Revista Espanola de Cardiologia, vol. 54, no. 5, pp. 624-634.
Lopera, Gustavo ; Castellanos, Agustin ; De Marchena, Eduardo. / Nuevos farmacos en insuficiencia cardíaca. In: Revista Espanola de Cardiologia. 2001 ; Vol. 54, No. 5. pp. 624-634.
@article{0f63e8d081ed46ac84209b5943226801,
title = "Nuevos farmacos en insuficiencia card{\'i}aca",
abstract = "Heart failure is a common and growing public health problem, with increasing incidence and prevalence over the last 2 decades. Despite improvements in its current management, heart failure is still associated with significant morbidity and mortality. This has motivated the search for newer therapeutic modalities, which are based on a better understanding on the pathophysiologic events that lead to heart failure. This review summarizes the potential role of new pharmacological agents in the treatment of heart failure. These potential new agents can be classified according to their role in the modulation of the main pathophysiologic abnormalities that characterized heart failure, that include: cellular-extracellular abnormalities, endothelial dysfunction, neurohormonal and immunologic activation.",
keywords = "Heart failure, New pharmacological agents, Pathophysiology",
author = "Gustavo Lopera and Agustin Castellanos and {De Marchena}, Eduardo",
year = "2001",
month = "5",
day = "1",
language = "Spanish",
volume = "54",
pages = "624--634",
journal = "Revista Espanola de Cardiologia",
issn = "0300-8932",
publisher = "Ediciones Doyma, S.L.",
number = "5",

}

TY - JOUR

T1 - Nuevos farmacos en insuficiencia cardíaca

AU - Lopera, Gustavo

AU - Castellanos, Agustin

AU - De Marchena, Eduardo

PY - 2001/5/1

Y1 - 2001/5/1

N2 - Heart failure is a common and growing public health problem, with increasing incidence and prevalence over the last 2 decades. Despite improvements in its current management, heart failure is still associated with significant morbidity and mortality. This has motivated the search for newer therapeutic modalities, which are based on a better understanding on the pathophysiologic events that lead to heart failure. This review summarizes the potential role of new pharmacological agents in the treatment of heart failure. These potential new agents can be classified according to their role in the modulation of the main pathophysiologic abnormalities that characterized heart failure, that include: cellular-extracellular abnormalities, endothelial dysfunction, neurohormonal and immunologic activation.

AB - Heart failure is a common and growing public health problem, with increasing incidence and prevalence over the last 2 decades. Despite improvements in its current management, heart failure is still associated with significant morbidity and mortality. This has motivated the search for newer therapeutic modalities, which are based on a better understanding on the pathophysiologic events that lead to heart failure. This review summarizes the potential role of new pharmacological agents in the treatment of heart failure. These potential new agents can be classified according to their role in the modulation of the main pathophysiologic abnormalities that characterized heart failure, that include: cellular-extracellular abnormalities, endothelial dysfunction, neurohormonal and immunologic activation.

KW - Heart failure

KW - New pharmacological agents

KW - Pathophysiology

UR - http://www.scopus.com/inward/record.url?scp=0343772997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343772997&partnerID=8YFLogxK

M3 - Article

C2 - 11412754

AN - SCOPUS:0343772997

VL - 54

SP - 624

EP - 634

JO - Revista Espanola de Cardiologia

JF - Revista Espanola de Cardiologia

SN - 0300-8932

IS - 5

ER -